Wu, YCYCWuWu, Cheng-YunCheng-YunWuTsai, SWSWTsaiChen, HJHJChenLiu, WJWJLiuLin, DDLinGong, TXTXGongYong, KTKTYongKIEN-VOON KONG2022-12-192022-12-1920222574-0970https://scholars.lib.ntu.edu.tw/handle/123456789/626591Singlet oxygen (1O2) has been recently identified as the key mechanism for depressing β-amyloid (Aβ) accumulation and neurofibrillary tangles (NFTs). Slow cell internalization and short half-life of photosensitizing effects still impede the application of nanophotosensitizers for photodynamic therapy (PDT). The current major challenge of using spiropyran for PDT is the extremely short half-life of its ring-opened isomer, merocyanine. Merocyanine is the center of generation of 1O2. Here, we report that the complexation of spiropyran onto Au nanoparticles greatly enhances the stability of merocyanine (half-life is 91.6 h). Additionally, Au nanoparticles sharply decelerate the reversion of merocyanine back to spiropyran (a ring-closed form) by modifying the energy configuration of merocyanine, resulting in generation of a long-lived 1O2 phototherapy response (24 h) in the intracellular environment for depressing tau aggregation (a 32% reduction of NFT formation).enplasmonic gold nanoparticles; photodynamic therapy; spiropyran hydrogel; nanomedicine; light-responsive nanomaterials; ALZHEIMERS-DISEASE; PHOTODYNAMIC THERAPY; CELLULAR UPTAKE; SPIROPYRAN; PROTEIN; BETA; PHOTODEGRADATION; PHOSPHORYLATION; PHOTOCHROMISM; RELEASEjournal article10.1021/acsanm.2c033262-s2.0-85139728245WOS:000876225600001https://api.elsevier.com/content/abstract/scopus_id/85139728245